Details for New Drug Application (NDA): 211504
✉ Email this page to a colleague
The generic ingredient in METHOCARBAMOL is aspirin; methocarbamol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Summary for 211504
Tradename: | METHOCARBAMOL |
Applicant: | Gland Pharma Ltd |
Ingredient: | methocarbamol |
Patents: | 0 |
Pharmacology for NDA: 211504
Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for 211504
Suppliers and Packaging for NDA: 211504
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METHOCARBAMOL | methocarbamol | SOLUTION;IM-IV | 211504 | ANDA | Dr.Reddy?s Laboratories Inc., | 43598-839 | 43598-839-36 | 10 VIAL in 1 CARTON (43598-839-36) / 10 mL in 1 VIAL (43598-839-11) |
METHOCARBAMOL | methocarbamol | SOLUTION;IM-IV | 211504 | ANDA | Gland Pharma Limited | 68083-317 | 68083-317-25 | 25 VIAL in 1 CARTON (68083-317-25) / 10 mL in 1 VIAL (68083-317-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;IM-IV | Strength | 1GM/10ML (100MG/ML) | ||||
Approval Date: | Oct 26, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription